Lancaster, PANCT06688396Now EnrollingIRB Ready

Dilated Cardiomyopathy Clinical Trial in Lancaster, PA

Access cutting-edge dilated cardiomyopathy treatment through this clinical trial at a research site in Lancaster. Study-provided care at no cost to qualified participants.

Sponsored by Lancaster General Hospital

Quick Self-Assessment

See if you qualify for this Lancaster location

Preparing your pre-screening questions…

Expert Care in Lancaster

Access dilated cardiomyopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dilated cardiomyopathy treatment provided free

Apply for This Lancaster Location

Check if you qualify for this dilated cardiomyopathy clinical trial in Lancaster, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lancaster

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lancaster site if eligible
  4. 4Begin participation

About This Dilated Cardiomyopathy Study in Lancaster

This is a prospective, single-arm clinical trial in which participants with dilated cardiomyopathy will invite their first degree relatives to undergo mobile cardiac, electrocardiogram screening.

Sponsor: Lancaster General Hospital

Who Can Participate

Inclusion Criteria

Male or female age ≥ 18 years
Confirmed diagnosis of non-ischemic DCM determined at the discretion of the treating physician and defined as LVEF ≤ 45% at any time during the clinical course of the patient
Must have at least one living adult FDR
Able to provide informed consent Inclusion Criteria (FDR)
Male or female age ≥ 18 years who are first-degree relatives of patients with DCM
Proband has provided informed consent
FDR able to provide informed verbal consent
Access to a smartphone or digital tablet with cellular data or Wi-Fi access

Exclusion Criteria

DCM attributed to any other secondary form of cardiomyopathy per the investigator's determination
Proband has previously informed FDR to undergo cardiac screening
Ischemic cause of reduced LVEF
evidence of myocardial infarction, inducible ischemia or chest pain on stress testing in absence of coronary angiogram to rule out ischemic disease
history of acute coronary syndromes (STEMI (ST-Elevation Myocardial Infarction), NSTEMI (Non-ST-Elevation Myocardial Infarction) or unstable angina) revascularization or ≥75% stenosis of either left main or Left Anterior Descending (LAD) or ≥75% stenosis of 2 major epicardial vessels on angiogram
Moderate or greater primary valvular abnormality not due to underlying cardiomyopathy
Congenital structural heart disease
Severe and untreated or untreatable hypertension
Cardiomyopathy due to acute or reversible conditions; examples include tachyarrhythmias, thyroid disorders, iron overload
Any secondary cause of reduced LVEF such as pregnancy, myocarditis, amyloidosis, sarcoidosis, exposure to toxins including alcohol, substance abuse or chemotherapeutic drug
(CPC Participants only) Home address outside of traveling range Exclusion Criteria (FDR)
Previously informed about cardiac screening or has completed cardiac screening by transthoracic echocardiogram (TTE)
Previously diagnosed with reduced LVEF
(CPC Participants only) Home address outside of traveling range

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lancaster?

Yes, this clinical trial (NCT06688396) has an active research site in Lancaster, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dilated Cardiomyopathy Treatment Options in Lancaster, PA

If you're searching for dilated cardiomyopathy treatment options in Lancaster, PA, this clinical trial (NCT06688396) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lancaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dilated cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dilated cardiomyopathy clinical trials near you to find additional studies recruiting in your area.

More Cardiomyopathy Trials in Lancaster, PA

See all cardiomyopathy clinical trials recruiting in Lancaster — not just this study.

Browse Cardiomyopathy Trials in Lancaster →

Browse More Trials by Condition

Cardiomyopathy TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in Lancaster?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lancaster, PA